AZoLifeSciences on MSN
Longevity Gene from Centenarians Reverses Heart Damage in Rare Genetic Disorder
A new breakthrough in a rare genetic disease which causes children to age rapidly has been discovered using 'longevity genes' ...
1don MSN
Longevity gene from supercentenarians offers hope for disease that causes rapid aging in children
A new breakthrough in a rare genetic disease which causes children to age rapidly has been discovered using 'longevity genes' ...
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK ...
Researchers from the University of Bristol and IRCCS MultiMedica showed that a gene linked to supercentenarians’ longevity ...
LONDON, UK / ACCESS Newswire / April 10, 2025 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company"), the only publicly listed longevity company in Europe, is excited to ...
(Alliance News) - Genflow Biosciences PLC on Friday reported strong data from a proof-of-concept clinical trial of its proprietary SIRT6-centenarian gene therapy for age-related decline in elderly ...
Genflow Advances World's First Longevity Gene Therapy Trial in Dogs with No Adverse Effects Reported LONDON, UK / ACCESS Newswire / August 18, 2025 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ...
LONDON, UK / ACCESS Newswire / September 15, 2025 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company"), the only publicly listed longevity company in Europe, today announces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback